Highly active antiretroviral therapy: Does it Sound toxic? | Zendy

Katijah KhozaShangase | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Highly active antiretroviral therapy: Does it Sound toxic?

Author(s) -

Katijah KhozaShangase

Publication year - 2011

Publication title -

journal of pharmacy and bioallied sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.268

H-Index - 36

eISSN - 0976-4879

pISSN - 0975-7406

DOI - 10.4103/0975-7406.76494

Subject(s) - antiretroviral therapy , medicine , sound (geography) , intensive care medicine , human immunodeficiency virus (hiv) , virology , viral load , acoustics , physics

The main objective of the current study is to monitor the auditory status in a group of adults with AIDS, receiving Highly Active Antiretroviral Therapy (HAART) (3TC -lamivudine, D4T - stavudine, and efavirenz) in a hospital outpatient clinic in Gauteng. A total sample of 54 adults (between the ages of 18 and 50 years) in the experimental group and 16 in the control group were assessed prospectively following a repeated measures design. All participants were assessed at baseline at three months, and at six months into the treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research